Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
RowAnalytics has secured seed round investment from global investors Astia Angels and Wheatsheaf Group Ltd, part of the Grosvenor Estate. Read More
The Mealplanner™ have partnered with MediSapiens to develop an application for helping users in the prevention of onset of type 2 diabetes. Read More
MediSapiens joins the recently announced 59M€ FinnGen project, that aims at improving human health through genetically profiling 500.000 Finns Read More
Optimizing emereging biopharma's clinical development and productivity Read More
How can you save 50% in study start time while delivering savings of 50% to customers? Read the case study... Read More
What do you see are the biggest challenges facing clinical trials today? How to manage, cleanse and transform your clinical trial data? Listen as Dr. Rizk shares highlights of innovative technology. Read More
Asymmetrex’s AlphaSTEM Test™ for specific counting of tissue stem cells is rapidly gaining greater interest. Scientist.com’s new newsletter, INNOV8, featured it for applications in drug development. Read More
MA stem cell biotech company Asymmetrex proposes that its new technology for certifying the specific dose and quality of tissue stem cells used in experimental treatments would improve FDA’s efforts. Read More
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results for the quarter ended June 30, 2017. Read More
Brand new Multi-tenant Science Building ***units available*** Read More